About Us
|
contact Us
|
Sitemap
Call us: +1-855-455-8662
|
Home
Business Solutions
Business Research Reports
Business Consulting
On-site Implementation & Training Programs
Industry Trackers
Subscription Solutions
Industry Reports
News
Press
Login
Register
Home
Market Research
Continuous Glucose Monitoring Devices Market Share, Trends And Forecast To 2029
Continuous Glucose Monitoring Devices Market By Component (Sensors, Transmitters & Receivers and Insulin Pumps), By Application (Diabetic Patients and Healthy Individuals) - Growth, Future Prospects, and Competitive Analysis, 2021 -2029
19 Nov 2017
Format
Request Sample
Report Summary
Table of contents
list of tables
list of figures
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Continuous Glucose Monitoring Devices Market
2.2. Global Continuous Glucose Monitoring Devices Market, By Component, 2023 (US$ Million)
2.3. Global Continuous Glucose Monitoring Devices Market, By Application, 2023 (US$ Million)
2.4. Global Continuous Glucose Monitoring Devices Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023
3. Continuous Glucose Monitoring Devices Market: Competitive Analysis
3.1. Market Positioning of Key Continuous Glucose Monitoring Devices Market Vendors
3.2. Strategies Adopted by Continuous Glucose Monitoring Devices Market Vendors
3.3. Key Industry Strategies
4. Continuous Glucose Monitoring Devices Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Continuous Glucose Monitoring Devices Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape
5. Continuous Glucose Monitoring Devices Market: By Component, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Sensors
5.3.2. Transmitters & Receivers
5.3.3. Insulin Pumps
6. Continuous Glucose Monitoring Devices Market: By Application, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Diabetic Patients
6.3.1.1. Type 1 Diabetes
6.3.1.2. Type 2 Diabetes
6.3.2. Healthy Individuals
7. North America Continuous Glucose Monitoring Devices Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Continuous Glucose Monitoring Devices Market: By Component, 2022-2032, USD (Million)
7.3. Continuous Glucose Monitoring Devices Market: By Application, 2022-2032, USD (Million)
7.4.Continuous Glucose Monitoring Devices Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Continuous Glucose Monitoring Devices Market: By Component, 2022-2032, USD (Million)
7.4.1.1.2. Continuous Glucose Monitoring Devices Market: By Application, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Continuous Glucose Monitoring Devices Market: By Component, 2022-2032, USD (Million)
7.4.1.2.2. Continuous Glucose Monitoring Devices Market: By Application, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Continuous Glucose Monitoring Devices Market: By Component, 2022-2032, USD (Million)
7.4.1.3.2. Continuous Glucose Monitoring Devices Market: By Application, 2022-2032, USD (Million)
8. UK and European Union Continuous Glucose Monitoring Devices Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Continuous Glucose Monitoring Devices Market: By Component, 2022-2032, USD (Million)
8.3. Continuous Glucose Monitoring Devices Market: By Application, 2022-2032, USD (Million)
8.4.Continuous Glucose Monitoring Devices Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Continuous Glucose Monitoring Devices Market: By Component, 2022-2032, USD (Million)
8.4.1.1.2. Continuous Glucose Monitoring Devices Market: By Application, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Continuous Glucose Monitoring Devices Market: By Component, 2022-2032, USD (Million)
8.4.1.2.2. Continuous Glucose Monitoring Devices Market: By Application, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Continuous Glucose Monitoring Devices Market: By Component, 2022-2032, USD (Million)
8.4.1.3.2. Continuous Glucose Monitoring Devices Market: By Application, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Continuous Glucose Monitoring Devices Market: By Component, 2022-2032, USD (Million)
8.4.1.4.2. Continuous Glucose Monitoring Devices Market: By Application, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Continuous Glucose Monitoring Devices Market: By Component, 2022-2032, USD (Million)
8.4.1.5.2. Continuous Glucose Monitoring Devices Market: By Application, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Continuous Glucose Monitoring Devices Market: By Component, 2022-2032, USD (Million)
8.4.1.6.2. Continuous Glucose Monitoring Devices Market: By Application, 2022-2032, USD (Million)
9. Asia Pacific Continuous Glucose Monitoring Devices Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Continuous Glucose Monitoring Devices Market: By Component, 2022-2032, USD (Million)
9.3. Continuous Glucose Monitoring Devices Market: By Application, 2022-2032, USD (Million)
9.4.Continuous Glucose Monitoring Devices Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Continuous Glucose Monitoring Devices Market: By Component, 2022-2032, USD (Million)
9.4.1.1.2. Continuous Glucose Monitoring Devices Market: By Application, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Continuous Glucose Monitoring Devices Market: By Component, 2022-2032, USD (Million)
9.4.1.2.2. Continuous Glucose Monitoring Devices Market: By Application, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Continuous Glucose Monitoring Devices Market: By Component, 2022-2032, USD (Million)
9.4.1.3.2. Continuous Glucose Monitoring Devices Market: By Application, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Continuous Glucose Monitoring Devices Market: By Component, 2022-2032, USD (Million)
9.4.1.4.2. Continuous Glucose Monitoring Devices Market: By Application, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Continuous Glucose Monitoring Devices Market: By Component, 2022-2032, USD (Million)
9.4.1.5.2. Continuous Glucose Monitoring Devices Market: By Application, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Continuous Glucose Monitoring Devices Market: By Component, 2022-2032, USD (Million)
9.4.1.6.2. Continuous Glucose Monitoring Devices Market: By Application, 2022-2032, USD (Million)
10. Latin America Continuous Glucose Monitoring Devices Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Continuous Glucose Monitoring Devices Market: By Component, 2022-2032, USD (Million)
10.3. Continuous Glucose Monitoring Devices Market: By Application, 2022-2032, USD (Million)
10.4.Continuous Glucose Monitoring Devices Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Continuous Glucose Monitoring Devices Market: By Component, 2022-2032, USD (Million)
10.4.1.1.2. Continuous Glucose Monitoring Devices Market: By Application, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Continuous Glucose Monitoring Devices Market: By Component, 2022-2032, USD (Million)
10.4.1.2.2. Continuous Glucose Monitoring Devices Market: By Application, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Continuous Glucose Monitoring Devices Market: By Component, 2022-2032, USD (Million)
10.4.1.3.2. Continuous Glucose Monitoring Devices Market: By Application, 2022-2032, USD (Million)
11. Middle East and Africa Continuous Glucose Monitoring Devices Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Continuous Glucose Monitoring Devices Market: By Component, 2022-2032, USD (Million)
11.3. Continuous Glucose Monitoring Devices Market: By Application, 2022-2032, USD (Million)
11.4.Continuous Glucose Monitoring Devices Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Continuous Glucose Monitoring Devices Market: By Component, 2022-2032, USD (Million)
11.4.1.1.2. Continuous Glucose Monitoring Devices Market: By Application, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Continuous Glucose Monitoring Devices Market: By Component, 2022-2032, USD (Million)
11.4.1.2.2. Continuous Glucose Monitoring Devices Market: By Application, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Continuous Glucose Monitoring Devices Market: By Component, 2022-2032, USD (Million)
11.4.1.3.2. Continuous Glucose Monitoring Devices Market: By Application, 2022-2032, USD (Million)
12. Company Profile
12.1. Abbott Laboratories
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. AgaMatrix, Inc.
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Arkray USA, Inc.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. ConvaTec, Inc.
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Dexcom, Inc.
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Echo Therapeutics, Inc.
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. F. Hoffmann-La Roche Ltd.
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Glucovation
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. GlySens Incorporated
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. GlySure
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. Johnson & Johnson
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives
12.12. Medtronic plc.
12.12.1. Company Overview
12.12.2. Financial Performance
12.12.3. Product Portfolio
12.12.4. Strategic Initiatives
12.13. OrSense
12.13.1. Company Overview
12.13.2. Financial Performance
12.13.3. Product Portfolio
12.13.4. Strategic Initiatives
12.14. Pinnacle Technology
12.14.1. Company Overview
12.14.2. Financial Performance
12.14.3. Product Portfolio
12.14.4. Strategic Initiatives
12.15. Senseonics Holdings, Inc.
12.15.1. Company Overview
12.15.2. Financial Performance
12.15.3. Product Portfolio
12.15.4. Strategic Initiatives
12.16. Tandem Diabetes Care
12.16.1. Company Overview
12.16.2. Financial Performance
12.16.3. Product Portfolio
12.16.4. Strategic Initiatives
Choose Licence Type
Single User Licence
$4325
Multi User license
$6325
Corporate license
$12650
Buy Now
Quick Contact
+1-855-455-8662
+91 77559-81103
sales@acutemarketreports.com
View Other Reports
Automotive
986
Chemicals and Materials
684
Consumer Goods
184
Energy
124
Food & Beverages
321
Medical Devices
178
Pharmaceutical & Healthcare
78
Technology
234